Metraipolis › archive › dc_494f76c4bd0d

Efficacy of Inebilizumab in N-MOmentum Trial Participants With or Without Prior Immunosuppressants — Europe PMC PMID:42117361

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42117361
DOI
10.1002/acn3.70426
License (as archived)
solo-consultazione
Archived
2026-11-02T11:52:05.840Z
SHA-256 of the archived text
8a50f4ed79a88950bdf89ca8ffc60bb540c4e919a29c3b4cd2548f23d19cd556
Stable URL of this page
https://metraipolis.com/documento/dc_494f76c4bd0d

How to cite

Efficacy of Inebilizumab in N-MOmentum Trial Participants With or Without Prior Immunosuppressants — Europe PMC PMID:42117361 — Europe PMC (en), https://europepmc.org/article/MED/42117361 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_494f76c4bd0d (Metraipolis archive dc_494f76c4bd0d, sha256 8a50f4ed79a88950bdf89ca8ffc60bb540c4e919a29c3b4cd2548f23d19cd556)
BibTeX
@misc{dc494f76c4bd0d,
  title = {Efficacy of Inebilizumab in N-MOmentum Trial Participants With or Without Prior Immunosuppressants — Europe PMC PMID:42117361},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42117361},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_494f76c4bd0d; sha256 8a50f4ed79a88950bdf89ca8ffc60bb540c4e919a29c3b4cd2548f23d19cd556},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42117361. Agents can read the archived copy with the MCP tool read_document.